9 patents
Utility
Formulations of AG10
6 Oct 22
The present disclosure provides high-load tablet formulations of AG10 or a pharmaceutically acceptable salt thereof.
Jesper JERNELIUS, Mark Michael MENNING
Filed: 18 Jan 22
Utility
Formulations of AG10
1 Mar 22
The present disclosure provides high-load tablet formulations of AG10 or a pharmaceutically acceptable salt thereof.
Jesper Jernelius, Mark Michael Menning
Filed: 16 Aug 19
Utility
Processes for Preparing AG-10, Its Intermediates, and Salts Thereof
10 Feb 22
Pooran Chand, Yogesh Kumar Gupta, Rakesh Kumar Kumawat, Mamoun Alhamadsheh, Robert Zamboni
Filed: 17 Jun 21
Utility
Methods of Treating TTR Amyloidosis Using AG10
20 Jan 22
Described herein are methods for treating transthyretin (TTR) amyloidosis in a subject.
Uma SINHA, Satish RAO
Filed: 27 May 21
Utility
Processes for preparing AG-10, its intermediates, and salts thereof
3 Aug 21
Pooran Chand, Yogesh Kumar Gupta, Rakesh Kumar Kumawat, Mamoun Alhamadsheh, Robert Zamboni
Filed: 7 Nov 19
Utility
Methods of treating TTR amyloidosis using AG10
13 Jul 21
Described herein are methods for treating transthyretin (TTR) amyloidosis in a subject.
Uma Sinha, Satish Rao
Filed: 22 Mar 19
Utility
Processes for Preparing AG-10, Its Intermediates, and Salts Thereof
5 Aug 20
Pooran Chand, Yogesh Kumar Gupta, Rakesh Kumar Kumawat, Mamoun Alhamadsheh, Robert Zamboni
Filed: 6 Nov 19
Utility
Formulations of AG10
19 Feb 20
The present disclosure provides high-load tablet formulations of AG10 or a pharmaceutically acceptable salt thereof.
Jesper Jernelius, Mark Michael Menning
Filed: 15 Aug 19
Utility
Process for preparing AG-10, its intermediates, and salts thereof
23 Dec 19
Pooran Chand, Yogesh Kumar Gupta, Rakesh Kumar Kumawat, Mamoun Alhamadsheh, Robert Zamboni
Filed: 15 Feb 18
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first